Total Visits

Views
Subgroup analyses from an international, doubleblind, randomised, phase 3 trial evaluating the effect of denosumab on bone metastasis-free survival in men with castrate-resistant prostate cancer61

Select a period of time:

Views

Views
December 20251
January 20261
February 20260
March 20265
April 20261
May 20266
June 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States7
Argentina1
Germany1
Egypt1
United Kingdom1
Honduras1
Lithuania1
Mexico1
 

Top cities views

Views
Cairo1
Catamarca1
Elyria1
Frankfurt am Main1
London1
Mexico City1
Phoenix1